Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Periostat tablets for periodontitis granted dental practitioners formulary status in the UK

Aug. 14, 2001

Biora enters distribution agreement with USBiomaterials for new periodontal disease product

Aug. 10, 2001

Atridox receives approval in Switzerland

July 9, 2001

CollaGenex launches tablet formulation of Periostat

July 3, 2001

CollaGenex seeks pan-European approval for Periostat tablets

June 20, 2001

Role for melatonin in Rx of periodontal disease discussed at IBMS/ECTS meeting

June 13, 2001

ZymoGenetics and BioMimetic establish agreement for rhPDGF clinical development

June 6, 2001

Atrix's periodontal disease treatment approved in several European countries

May 8, 2001

OraPharma launches Arestin in the U.S. for adjunctive treatment of periodontal disease

April 6, 2001

OraPharma's Arestin cleared for U.S. launch

Feb. 20, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Aug. 15, 2025.
NME Digest: Q2 2025
BioWorld
A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...
Scemblix ticks Novartis earnings box; more ahead in CML
BioWorld
Novartis AG’s financial update included good news about Scemblix (asciminib), the first and only U.S. FDA-approved allosteric inhibitor for chronic myeloid...
Merck’s MK-2214 shows potential to slow Alzheimer’s pathology
BioWorld Science
Abnormal tau aggregation is a hallmark of Alzheimer’s disease (AD) and a major contributor to neurodegeneration, synaptic dysfunction, and progressive functional...